Skip to main content
James Goydos, MD, General Surgery, East Brunswick, NJ

James S Goydos MD

Surgical Oncology (Other than Breast)


American Association for Cancer Research (AACR); Clinical Cancer Research Journal

Join to view full profile
  • 1 Fernwood CourtEast Brunswick, NJ 08816

  • Phone+1 732-427-3573

Dr. Goydos is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. James Goydos is a general surgeon based in East Brunswick, NJ, with subspecialty training in surgical oncology. After graduating from Rutgers Robert Wood Johnson Medical School in 1988, he completed his General Surgical residency at the University of Connecticut in 1993, followed by his Surgical Oncology Fellowship at the University of Pittsburgh, which he completed in 1995 . Dr. Goydos has expertise in treating all stages of melanoma, other types of skin malignancies, as well as soft tissue sarcomas. His research includes publications on topics such as melanoma and cancer awareness. He has been involved in clinical trials studying Riluzole for patients with advanced melanoma and breast cancer. His accolades include several CMS Meaningful Use Certifications, Castle Connolly's Top Doctors listing, and recognition as an ACS Fellow.

Clinical Expertise

  • Skin cancer, Melanoma, Soft tissue cancer, Soft tissue sarcomas, Oncology, Surgical oncology (non-breast), Merkel cell carcinoma, Skin cancer surgery, Health education, Biochemistry

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Complex General Surgical Oncology, 1993 - 1995
  • University of Connecticut
    University of ConnecticutResidency, Surgery, 1988 - 1993
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1988

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1995 - 2027
  • PA State Medical License
    PA State Medical License 1993 - 1996
  • CT State Medical License
    CT State Medical License 1992 - 1993
  • Surgery
    American Board of Surgery Surgery

Awards, Honors, & Recognition

  • ACS Fellow
  • CMS Meaningful Use Stage 2 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013, 2015-2017

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Melanoma & Skin Cancer Patient & Caregiver Symposium 
    Cancer Institute Of New Jersey Cinj - 5/16/2017
  • Treatment of Locally and Regionally Advanced Melanoma 
    Rutgers Cancer Institute of New Jersey - 9/13/2014

Other

Authored Content

  • Can You Get a Sunburn in the Winter?December 2021
  • Can You Get a Sunburn in the Winter?December 2021
  • When Do Americans Get Their Freedom BackNovember 2021

Press Mentions

  • On Memorial Day, We Should Talk Skin Cancer in the Military
    On Memorial Day, We Should Talk Skin Cancer in the MilitaryMay 28th, 2022
  • When Do Americans Get Their Freedom Back?
    When Do Americans Get Their Freedom Back?September 14th, 2021
  • Biohaven Announces First Patient Treated in Clinical Research Collaboration At Rutgers Cancer Institute
    Biohaven Announces First Patient Treated in Clinical Research Collaboration At Rutgers Cancer InstituteMay 18th, 2020

Grant Support

  • Regulation of tumor released exosomes and glutamatergic signalingNational Cancer Institute2014–2017
  • Combination Therapy that Targets Glutamate Signaling in MelanomaNational Cancer Institute2010–2015
  • A Patient Oriented Research Program for Surgical OncologistsNational Cancer Institute2010–2015
  • Validation of Grm1 as a Therapeutic Target in MelanomaNational Cancer Institute2007–2013
  • A Phase II Trial of Riluzole in Patients with Advanced MelanomaNational Cancer Institute2009–2011

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: